Trade Summary

6 days ago, Kemble George, serving as Dir at Sagimet Biosciences Inc. (SGMT), sold 18,844 shares at $7.46 per share, for a total transaction value of $140,529.13. Following this transaction, Kemble George now holds 62,161 shares of SGMT.

This sale represents a 23.26% decrease in Kemble George's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 22, 2026 at 4:05 PM ET, 2 days after the trade was made.

Sagimet Biosciences Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.